Strikingly, CD138+ plasma cell counts displayed the largest discrepancies: a more than 50-fold increase in IC/BPS-HL samples (on average, 101 cells/field) as opposed to the UC cohort (2 cells/field; p < 0.0001; Fig. 2B). The gene discussed is SDC1; the disease is Hodgkins lymphoma.